Insmed share price logo

Insmed

NASDAQ: INSM

Large Cap

$111.12

+2.53

(+2.33%)

as on

Insmed Stock Performance

as on October 3, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $105.68
    $111.54
    downward going graph

    4.90%

    Downside

    0.38%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $90.39
    $212.75
    downward going graph

    18.66%

    Downside

    91.46%

    Upside

    downward going graph

Insmed share price movements today

Previous Close
$108.59
Open
$106.36
Volume
3.2M
Market Cap
$23.7B
Day's Low - High
$105.68 - $111.54
52 Week Low - High
$90.39 - $212.75

Insmed Historical Returns

1 Month Return
-12.28 %
3 Month Return
-0.43 %
1 Year Return
-29.29 %
3 Year Return
+ 356.91 %
5 Year Return
+ 305.84 %

Insmed Stock Fundamentals & Key Indicators

Check Insmed market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.7B

EPS (TTM)

-4.11

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-26.68

Industry PE ratio

8.52

PEG Ratio

-1.06

EBITDA

-770.0M

Revenue (TTM)

1.1B

Profit Margin

83.27%

Return On Equity TTM

-111.26%

Insmed vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Insmed with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$23.7B305.84%-26.6883.27%0.00%
StrongBuy$44.1B609.62%-23.340.00%0.00%
Neutral$75.4B-44.29%-24.08-12.57%0.00%
StrongBuy$132.5B180.98%30.1986.04%0.00%
Buy$78.1B28.80%17.6784.86%0.50%

Stock Returns calculator for Insmed Stock including INR - Dollar returns

The Insmed stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Insmed investment value today

Current value as on today

₹76,746

Returns

-₹23,254

(-23.25%)

Returns from Insmed Stock

-₹29,295 (-29.29%)

Dollar Impact

₹6,041 (+6.04%)

Analyst Recommendation on Insmed Stock

Based on 14 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 14 analysts, 100% of analysts recommend a 'BUY' rating for Insmed. Average target price of $197.74

Insmed Share Price Target

Get share price movements and forecasts by analysts on Insmed.

What analysts predicted

43.8%UPSIDE

Target Price

$197.74

Current Price

$111.12

Analyzed by

14 Analysts

High

$243

Target

$197.74

Low

$170

Insmed target price $197.74, a slight upside of 43.8% compared to current price of $111.12. According to 14 analysts rating.

Indian Investors' Interest in Insmed Stock

Search interest for Insmed Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-58% versus previous 30 day period

Insmed Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
75
90
93
104
92
107
142
263
305
425
Gross Profit
58
69
72
78
71
79
112
219
256
358
Operating Income
-145
-288
-213
-230
-248
-312
-366
-249
-200
-1
EBITDA
-133
-276
-196
-211
-232
-297
-345
-302
-136
14
Interest Expense
21
21
21
21
21
21
20
20
20
20
Depreciation
2
2
2
2
3
3
3
5
5
5
Income Before Tax
-156
-299
-219
-234
-255
-320
-368
-326
-162
-11
Income Tax Expense
0
0
1
1
0
1
1
1
1
1
Net Income
-157
-300
-220
-235
-256
-321
-370
-328
-163
-13
Net Profit Margin
76.88%
76.79%
77.34%
74.96%
77.08%
73.86%
79.37%
83.24%
83.82%
84.20%

Insmed Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
9
136
164
188
245
305
363
606
Gross Profit
-2
7
112
124
144
190
239
277
481
Operating Income
-188
-307
-235
-265
-375
-457
-709
-878
-1,176
EBITDA
-184
-295
-217
-250
-383
-447
-660
-818
-1,171
Interest Expense
5
25
27
29
40
26
81
84
83
Depreciation
2
4
10
14
14
10
10
11
16
Income Before Tax
-192
-324
-253
-292
-436
-480
-747
-910
-1,271
Income Tax Expense
0
0
0
1
-1
1
2
3
5
Net Income
-192
-324
-254
-294
-434
-481
-749
-913
-1,276
Net Profit Margin
0.00%
75.36%
82.26%
75.75%
76.57%
77.53%
78.52%
76.43%
79.41%

Insmed Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-157
-300
-220
-235
-256
-321
-370
-328
-163
-13
Operating Cash Flow
-184
-122
-180
-195
-262
-205
-219
-247
-222
-88
Investing Cash Flow
295
-6
-1,003
131
80
227
-762
389
265
24
Financing Cash Flow
3
781
397
159
28
857
33
33
29
27
Change in Cash
113
651
-785
93
-151
881
-949
175
71
-37

Insmed Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-192
-324
-254
-294
-434
-481
-749
-913
-1,276
Operating Cash Flow
-159
-257
-250
-219
-363
-400
-536
-683
-935
Investing Cash Flow
-3
-14
-42
-6
-64
-34
-223
-583
-64
Financing Cash Flow
381
386
285
271
612
793
168
1,341
954
Change in Cash
218
113
-7
45
184
357
-591
72
-44

Global Institutional Holdings in Insmed

Check out the Institutions with significant holdings in Insmed.

Funds
Holdings
Vanguard
9.14%
VANGUARD INDEX FUNDS
8.20%
JPMorgan Trust II
5.58%
Felix Baker
4.03%
iShares
3.63%

Insmed News & Key Events

  • img

    Today's Timeline - 30 March

    Tue, 06:55 AM

    -

    Insmed shares rise 5.52% after Morgan Stanley upgrades rating and price target, citing optimism for Brinsupri launch.

Insights on Insmed

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 92.82M → 425.48M (in $), with an average increase of 25.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, INSM stock has moved up by 356.9%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, INSM has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -370.02M → -13.24M (in $), with an average increase of 416.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 566.9% return, outperforming this stock by 596.2%

About Insmed

Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
OrganisationInsmed
Headquarters700 US Highway 202/206, Bridgewater, NJ, 08807, US
IndustryBiotechnology
CEOWilliam H. Lewis

Key Management of Insmed

Name

Title

Ms. Claire Mulhearn

Vice President of Corporate Communications

Ms. S. Nicole Schaeffer M.B.A.

Chief People Strategy Officer

Bryan Dunn

Vice President of Investor Relations

Ms. Sara M. Bonstein M.B.A.

Chief Financial Officer

Mr. Roger Adsett M.B.A.

Chief Operating Officer

Mr. Michael Alexander Smith J.D.

Chief Legal Officer & Corporate Secretary

Dr. Martina Flammer M.B.A., M.D.

Chief Medical Officer

Mr. Brian K. Kaspar Ph.D.

Chief Scientific Officer

Ms. Christie Camelio

Chief Compliance Officer

Mr. William H. Lewis J.D., M.B.A.

President, CEO & Chairman

FAQs

What is Insmed share price today?

Insmed share price today is $111.12 as on at the close of the market. Insmed share today touched a day high of $111.54 and a low of $105.68.

What is the 52 week high and 52 week low for Insmed share?

Insmed share touched a 52 week high of $212.75 on and a 52 week low of $90.39 on . Insmed stock price today i.e. is closed at $111.12,which is 47.77% down from its 52 week high and 22.93% up from its 52 week low.

What is Insmed's market capitalisation today?

Insmed market capitalisation is $0.02T as on .

How to invest in Insmed Stock (INSM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Insmed on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Insmed Stock (INSM) from India?

Indian investors can start investing in Insmed (INSM) shares with as little as ₹96.300003051758 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹963.00 in Insmed stock (as per the Rupee-Dollar exchange rate as on ). Based on Insmed share’s latest price of $111.12 as on October 3, 2026 at 8:46 am IST, you will get 0.0900 shares of Insmed. Learn more about fractional shares .

What are the returns that Insmed has given to Indian investors in the last 5 years?

Insmed stock has given 305.84% share price returns and 28.69% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?